SMIH Summit Healthcare Acquisition Corp - Ordinary Shares - Class A

About SMIH

YS Biopharma Co. Ltd. engages in discovering, developing, manufacturing, and commercializing vaccines and therapeutic biologics for infectious diseases and cancer. It focuses on developing PIKA technology platform. It operates through the People's Republic of China and Other Countries or Regions. The company was founded by Yi Zhang on November 16, 2020 and is headquartered in Beijing, China.
50

Neutral Sentiment

How do you feel about SMIH?

Advertisement|Remove ads.